Ab-soft The Brief Pain Inventory ii Manual de usuario

The Brief Pain InventoryUser GuideCharles S. Cleeland, PhDiiCopyright and Terms of UseThe Brief Pain Inventory (BPI) copyright is held byDr. Charles S

15Chapter 2BPI References: Use of the BPI inVarious StudiesThe Brief Pain Inventory has been used in morethan 400 studies worldwide. Here we present B

17induced pain flare after palliative radiotherapy for bonemetastases-a pilot study. Support Care Cancer 15(6): 643-647,6/2007.8. Cleeland CS. The mea

19metastases in cancer patients]. Nippon Igaku HoshasenGakkai Zasshi 65(4): 399-410, 10/2005.24. Pistevou-Gompaki K, Kouloulias VE, Varveris C, Mystak

219. Holtan A, Aass N, Nordoy T, Haugen DF, Kaasa S, Mohr W,Kongsgaard UE. Prevalence of pain in hospitalised cancerpatients in Norway: a national sur

23Cooperative Oncology Group. Ann Oncol 16(6): 972-980,6/2005.11. Du Pen SL, Du Pen AR, Polissar N, Hansberry J, Kraybill BM,Stillman M, Panke J, Ever

2528. Liang SY, Yates P, Edwards H, Tsay SL. Factors influencingopioid-taking self-efficacy and analgesic adherence inTaiwanese outpatients with cance

27morphine pre-treated and opioid naive patients withtransdermal fentanyl. Int J Cancer 107(3): 486-492, 11/2003.46. Mystakidou K, Parpa E, Katsouda E

29population of men with prostate cancer. Br J Cancer 85(4):497-503, 8/2001.62. Sandblom G, Carlsson P, Sennfalt K, Varenhorst E. Apopulation-based st

31Depressive Disorders1. Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, WatkinJG, Schatzberg AF. Duloxetine 60 mg once-daily in thetreatment of

337. Schiffmann R, Kopp JB, Austin HA, III, Sabnis S, Moore DF,Weibel T, Balow JE, Brady RO. Enzyme replacement therapy inFabry disease: a randomized

iTable of ContentsChapter 1... 1Development of the Brief Pain Inventory ...1B

358. Newshan G, Lefkowitz M. Transdermal fentanyl for chronicpain in AIDS: a pilot study. J Pain Symptom Manage 21(1): 69-77, 1/2001.9. Simmonds MJ, N

378. Chae J, Mascarenhas D, Yu DT, Kirsteins A, Elovic EP, FlanaganSR, Harvey RL, Zorowitz RD, Fang ZP. Poststroke shoulder pain:its relationship to m

3928. Renzenbrink GJ, IJzerman MJ. Percutaneous neuromuscularelectrical stimulation (P-NMES) for treating shoulder pain inchronic hemiplegia. Effects

41valproate in patients with cancer-related neuropathic pain. JPain Symptom Manage 21(3): 204-209, 3/2001.9. Katz NP, Gammaitoni AR, Davis MW, Dworkin

435. Cowan DT, Wilson-Barnett J, Griffiths P, Vaughan DJ, GondhiaA, Allan LG. A randomized, double-blind, placebo-controlled,cross-over pilot study to

45findings from a pilot study. J Opioid Manag 3(3): 145-154,5/2007.22. Thie NM, Prasad NG, Major PW. Evaluation of glucosaminesulfate compared to ibup

475. Davison SN. Pain in hemodialysis patients: prevalence, cause,severity, and management. Am J Kidney Dis 42(6): 1239-1247,12/2003.6. Dell DD, Weave

49placebo-controlled clinical trial. J Epidemiol Biostat 5(6): 359-365, 2000.23. Tittle MB, McMillan SC, Hagan S. Validating the brief paininventory f

51acute oncology setting. Asia-Pacific Journal of ClinicalOncology 3(2): 89-94, 6/2007.12. Cleeland CS, Ryan KM. Pain assessment: global use of theBri

53Tools: Is the Content Appropriate for Use in Palliative Care? JPain Symptom Manage 32(6): 567-580, 12/2006.29. Janjan NA, Payne R, Gillis T, Podolof

1Chapter 1Development of the Brief PainInventoryThe Brief Pain Inventory (BPI) has become one ofthe most widely used measurement tools forassessing cl

55the time trade-off. Journal of Clinical Epidemiology 60(10):1029-1033, 10/2007.46. Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R,Grond S,

57osteoarthritic pain. J Pain Symptom Manage 31(1): 48-57,1/2006.64. Wu EQ, Borton J, Said G, Le TK, Monz B, Rosilio M, Avoinet S.Estimated prevalence

599. Uki J, Mendoza T, Cleeland CS, Nakamura Y, Takeda F. A briefcancer pain assessment tool in Japanese: the utility of theJapanese Brief Pain Invent

6116. Cleeland CS. Measurement and prevalence of pain incancer. Semin Oncol Nurs 1(2): 87-92, 5/1985.17. Cleeland CS. How to treat a "construct&q

63BR, Stauffer JW, von ST, White RE, Witter J, Zavisic S.Interpreting the clinical importance of treatment outcomes inchronic pain clinical trials: IM

6551. Li KK, Harris K, Hadi S, Chow E. What should be the optimal cutpoints for mild, moderate, and severe pain? Journal ofPalliative Medicine 10(6):

6769. Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the BriefPain Inventory for chronic nonmalignant pain. J Pain 5(2): 133-137, 3/2004.70. Y

3would be easily translated for non-English-speaking patients; and(e) would capture not only pain severity, but also the perceptionof how pain interfe

5Early Version: The Wisconsin Brief Pain QuestionnaireThe first version of our pain measure was the Wisconsin Brief PainQuestionnaire (BPQ; Daut &

7in clinical and research applications. The short form is typicallywhat is referred to when the BPI is cited in research, and it is theversion we desc

9from 80 centers were enrolled in the study (Cleeland et al., 1994).Factor analysis verified the two separate factors, pain severity andinterference,

11Test-Retest Reliability and Alternate-Forms Reliability: the HindiTranslationFinally, one study combined an examination of both test-retestreliabili

13clinical trials: IMMPACT recommendations. J Pain 9(2): 105-121,2/2008.Food and Drug Administration. Guidelines for Industry (draft).Patient-Reported